Substantial Improvement in UK Cervical Cancer Survival with Chemoradiotherapy: Results of a Royal College of Radiologists' Audit

被引:83
作者
Vale, C. L. [2 ]
Tierney, J. F. [2 ]
Davidson, S. E. [3 ]
Drinkwater, K. J. [4 ]
Symonds, P. [1 ]
机构
[1] Univ Leicester, Dept Canc Studies & Mol Med, Leicester Royal Infirm, Leicester LE1 5WW, Leics, England
[2] MRC, Clin Trials Unit, Meta Anal Grp, London, England
[3] Christie NHS Fdn Trust, Manchester, Lancs, England
[4] Royal Coll Radiologists, London, England
基金
英国医学研究理事会;
关键词
Audit; cervical cancer; chemoradiotherapy; CARCINOMA; CISPLATIN; RADIATION; CHEMOTHERAPY; RADIOTHERAPY; GLOSSARY; TRIALS;
D O I
10.1016/j.clon.2010.06.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aims: To compare survival and late complications between patients treated with chemoradiotherapy and radiotherapy for locally advanced cervix cancer. Materials and methods: A Royal College of Radiologists' audit of patients treated with radiotherapy in UK cancer centres in 2001-2002. Survival, recurrence and late complications were assessed for patients grouped according to radical treatment received (radiotherapy, chemoradiotherapy, postoperative radiotherapy or chemoradiotherapy) and non-radical treatment. Late complication rates were assessed using the Franco-Italian glossary. Results: Data were analysed for 1243 patients from 42 UK centres. Overall 5-year survival was 56% (any radical treatment); 44% (radical radiotherapy); 55% (chemoradiotherapy) and 71% (surgery with postoperative radiotherapy). Overall survival at 5 years was 59% (stage IB), 44% (stage IIB) and 24% (stage IIIB) for women treated with radiotherapy, and 65% (stage IB), 61% (stage IIB) and 44% (stage IIIB) for those receiving chemoradiotherapy. Cox regression showed that survival was significantly better for patients receiving chemoradiotherapy (hazard ratio = 0.77, 95% confidence interval 0.60-0.98: P=0.037) compared with those receiving radiotherapy taking age, stage, pelvic node involvement and treatment delay into account. The grade 3/4 late complication rate was 8% (radiotherapy) and 10% (chemoradiotherapy). Although complications continued to develop up to 7 years after treatment for those receiving chemoradiotherapy, there was no apparent increase in overall late complications compared with radiotherapy alone when other factors were taken into account (hazard ratio = 0.94, 95% confidence interval 0.71-1.245; P = 0.667). Discussion: The addition of chemotherapy to radiotherapy seems to have improved survival compared with radiotherapy alone for women treated in 2001-2002, without an apparent rise in late treatment complications. (C) 2010 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:590 / 601
页数:12
相关论文
共 18 条
[1]  
[Anonymous], UK CERV CANC INC STA
[2]   A GLOSSARY FOR REPORTING COMPLICATIONS OF TREATMENT IN GYNECOLOGICAL CANCERS [J].
CHASSAGNE, D ;
SISMONDI, P ;
HORIOT, JC ;
SINISTRERO, G ;
BEY, P ;
ZOLA, P ;
PERNOT, M ;
GERBAULET, A ;
KUNKLER, I ;
MICHEL, G .
RADIOTHERAPY AND ONCOLOGY, 1993, 26 (03) :195-202
[3]   Assessment of morbidity in carcinoma of the cervix: a comparison of the LENT SOMA scales and the Franco-Italian glossary [J].
Davidson, SE ;
Burns, MP ;
Routledge, JA ;
Swindell, R ;
Bentzen, SM ;
West, CML .
RADIOTHERAPY AND ONCOLOGY, 2003, 69 (02) :195-200
[4]   Improving the capture of adverse event data in clinical trials: The role of the international atomic energy agency [J].
Davidson, Susan E. ;
Trotti, Andy ;
Ataman, Oezlem U. ;
Seong, Jinsfl ;
Lau, Fen Nee ;
Da Motta, Neiro W. ;
Jeremic, Branislav .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (04) :1218-1221
[5]   National audit of the management and outcome of carcinoma of the cervix treated with radiotherapy in 1993 [J].
Denton, AS ;
Bond, SJ ;
Matthews, S ;
Bentzen, SM ;
Maher, EJ .
CLINICAL ONCOLOGY, 2000, 12 (06) :347-353
[6]   Chemoradiation in Gynaecological Cancer [J].
Goonatillake, S. ;
Khong, R. ;
Hoskin, P. .
CLINICAL ONCOLOGY, 2009, 21 (07) :566-572
[7]   Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma [J].
Keys, HM ;
Bundy, BN ;
Stehman, FB ;
Muderspach, LI ;
Chafe, WE ;
Suggs, CL ;
Walker, JL ;
Gersell, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (15) :1154-1161
[8]   Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer [J].
Morris, M ;
Eifel, PJ ;
Lu, JD ;
Grigsby, PW ;
Levenback, C ;
Stevens, RE ;
Rotman, M ;
Gershenson, DM ;
Mutch, DG .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (15) :1137-1143
[9]  
*NAT CANC I, 1999, NCI ISS CLIN ANN CER, V99
[10]  
Peters William A. III, 1999, Gynecologic Oncology, V72, P443